The Effects of Prescribed Medications on Depressive Symptoms and Neurocognitive Performance in People With HIV
Clinical Infectious Diseases · 2025
DOI: 10.1093/cid/ciae518 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Asante R Kamkwalala und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: HIV Infections, Depression, Anti-HIV Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIDA NIH HHS, NIMH NIH HHS.
Themen: Depression
Abstract (Originalsprache)
Background
Alterations in brain function and structure, such as depression and neurocognitive impairment, continue to occur in people with human immunodeficiency virus (HIV, PWH) taking suppressive antiretroviral therapy (ART). The lifespan of PWH has improved but the healthspan remains worse than people without HIV, in part because of aging-related diseases. As a result, polypharmacy is common and increases the risk of drug-drug interactions and adverse reactions.
Methods
This cross-sectional project investigated the relationship between 7 medication-related metrics (including anticholinergic burden), depressive symptoms, and neurocognitive performance in 491 PWH at a single center in the United States. All participants were taking ART and had plasma HIV RNA ≤ 200 copies/mL.
Results
Participants had taken ART for a mean of 6.5 years, and most (57.6%) had CD4+ T-cells >500/µL. All 7 medication-related metrics were associated with worse global neurocognitive performance (P value <.0001 to .0087). Multivariable models confirmed that higher anticholinergic burden (P = .040) and use of benzodiazepines (P = .033), antidepressants (P = .0011), and more total medications (P = .059) were associated with more depressive symptoms (model P < .0001). Use of benzodiazepines (P = .0024) and opiates (P = .043) along with higher anticholinergic burden (P = .066) were also associated with worse neurocognitive performance. Benzodiazepine use was associated with worse performance in all domains and opiate use was associated with worse performance in processing speed, motor function, executive function, and working memory.
Conclusions
Use of benzodiazepines, opiates, and anticholinergic drugs contribute to cognitive and mood disorders in PWH. When possible, modifying or deprescribing medications may be beneficial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA.
- Department of Psychiatry, University of Texas Health Science Center, San Antonio, Texas, USA.
- Department of Infectious Diseases, University of Georgia, Athens, Georgia, USA.
- Department of Health and Biomedical Sciences, University of Texas Rio Grande Valley, Brownsville, Texas, USA.
- Department of Pharmacy Practice, University at Buffalo, Buffalo, New York, USA.
- Department of Medicine, University of California, San Diego, California, USA.
ORCID-Profile: Asante R Kamkwalala, Ankita Garg, Qing Ma, Erin Sundermann, Ronald J Ellis, Mattia Trunfio, David J Moore, Scott L Letendre
Förderung
- NIAID NIH HHS
- NIDA NIH HHS
- NIMH NIH HHS
- NIA NIH HHS
- NINDS NIH HHS
- National Institute on Aging
- National Institute of Mental Health
- National Institute on Drug Abuse
Zitieren
APA
Kamkwalala, A. R., Matthews, A., Garg, A., Roy, U., Ma, Q., Karris, M., Sundermann, E., Ellis, R. J., Riggs, P. K., Trunfio, M., Blanchard, J., Moore, D. J., Rubin, L. H., & Letendre, S. L. (2025). The Effects of Prescribed Medications on Depressive Symptoms and Neurocognitive Performance in People With HIV. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae518
Vancouver
Kamkwalala AR, Matthews A, Garg A, Roy U, Ma Q, Karris M, et al. The Effects of Prescribed Medications on Depressive Symptoms and Neurocognitive Performance in People With HIV. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciae518
BibTeX
@article{Kamkwalala2025,
author = {Kamkwalala, Asante R and Matthews, Avery and Garg, Ankita and Roy, Upal and Ma, Qing and Karris, Maile and Sundermann, Erin and Ellis, Ronald J and Riggs, Patricia K and Trunfio, Mattia and Blanchard, Jennifer and Moore, David J and Rubin, Leah H and Letendre, Scott L},
title = {The Effects of Prescribed Medications on Depressive Symptoms and Neurocognitive Performance in People With HIV},
journal = {Clinical Infectious Diseases},
year = {2025},
doi = {10.1093/cid/ciae518}
}
EUVIMED